MET and rheumatoid arthritis: As shown in Figure 3C, and according to the Degree value, the core targets of P-A drug pair for RA treatment were mainly PIK3R1, EGFR, PIK3CA, PTPN11, JAK1, PTPN1, MET, and HSP90AA1.